IN BRIEF: Haleon buys GBP230 million in shares from Pfizer

Haleon PLC - Weybridge, Surrey-based consumer healthcare firm spun-out of GSK PLC in 2022 - ...

Alliance News 3 October, 2024 | 4:29PM
Email Form Facebook Twitter LinkedIn RSS

Haleon PLC - Weybridge, Surrey-based consumer healthcare firm spun-out of GSK PLC in 2022 - Announces it has completed an off-market purchase of 60.5 million shares from Pfizer Inc, for an aggregate purchasing price of GBP230 million. It has cancelled 30.2 million shares and 30.4 million will be held as treasury shares. The total number of issued shares by Haleon now stands at 9.08 billion, with voting rights attributed to 9.05 billion.

Current stock price: 388.10 pence, closed 0.7% lower in London on Thursday afternoon

12-month change: up 14%

By Emily Parsons, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Haleon PLC 393.65 GBX 0.73
Pfizer Inc 28.41 USD -0.68

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures